Isoprenoids as mediators of the biological effects of statins.

James K Liao

Journal: The Journal of clinical investigation 2002;110(3):285-8

PMID: 12163444

Free Full Text on American Society for Clinical Investigation View on PubMed

Abstract

Address: Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02139, USA. [email protected]

DOI: 10.1172/JCI16421

Link outs

Free resources

Full Text Sources:

Medical:

https://medlineplus.gov/cholesterolmedicines.html

Other Literature Sources:

https://www.lens.org/lens/search/patent/list?q=ref...

Subscription / membership required

Full Text Sources:

http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=linko...

MeSH Terms: Cardiovascular Diseases, Cholesterol, Clinical Trials as Topic, Humans, Hydroxymethylglutaryl CoA Reductases, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Polyisoprenyl Phosphates, Protein Prenylation

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.